Skip to main content
. Author manuscript; available in PMC: 2013 Jun 21.
Published in final edited form as: J Biomed Mater Res A. 2010 Mar 1;92(3):913–921. doi: 10.1002/jbm.a.32303

TABLE II.

Histomorphometry

Bone Marrow Fibrous tissue
Ongrowth
  P-Ti   3 (0–3) 33 (21–50) 56 (45–76)
  P-HA 51 (20–62)a 33 (10–35) 15 (2–71)
  E-HA 18 (5–25)a 54 (32–68)b 21 (17–64)a
  E-HA-collagen 21 (13–27)a 53 (36–69)b 21 (1–55)
0–500 µm
  P-Ti 11 (10–16) 71 (52–77) 13 (12–17)
  P-HA 18 (11–27) 65 (61–69) 9 (1–27)
  E-HA 24 (11–28)a 67 (51–75) 11 (4–16)
  E-HA-collagen 19 (14–32) 67 (58–79) 4 (1–12)a
500–1000 µm
  P-Ti 11 (6–18) 80 (72–88) 0.1 (0–0.7)
  P-HA 13 (10–29) 81 (69–85) 0 (0–0.2)
  E-HA 19 (14–22)a 75 (72–83) 0 (0–0.5)
  E-HA-collagen 19 (14–27) 76 (62–79) 0.3 (0–2)

Density (percentage) of bone, marrow-like and fibrous tissue at the implant surface, concentric zone 0–500 µm and 500–1000 µm.

Median, interquartile ranges. n = 7.

P-Ti, plasma spray titanium alloy; P-HA, plasma spray hydroxyapatite coating; E-HA, electrochemical-assisted hydroxyapatite coating; E-HA-Col, electrochemical-assisted hydroxyapatite mineralised collagen coating.

a

p < 0.05 compared with titanium.

b

p < 0.05 compared with HA plasma.